Vir Biotechnology, a commercial-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases, is tackling the ...

Get global perspectives and insights from CEOs on the biggest stories in business. Ten years in as CEO, Nadella has turned Microsoft into the world’s most valuable company and one of the top ...

Vir Sanghvi is the best-known Indian journalist of his generation. His career straddles print, television, books and now, new media. Vir Sanghvi was born in London in 1956 and educated at Mayo College ...

On Wednesday, Vir Biotechnology Inc (NASDAQ:VIR) announced new preliminary data from its Phase 2 SOLSTICE hepatitis delta clinical trial evaluating tobevibart and elebsiran for chronic hepatitis ...

Two new drugs are set to transform the weight-loss landscape. People are losing more weight on these medicines than they ever did on the fad diets.

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on ...

Actor and stand-up comedian Vir Das recently shared his insights on the difference between acting and stand-up comedy. He said that even the best actors in the world cannot replicate the unique ...